Wednesday, May 3, 2023 (09:00 - 11:00) GMT+1
Who is the forum addressed to?
Why attend?
Background
Demand for healthcare is growing relentlessly driven by growing and ageing populations, higher incomes, and greater expectations of services as well as advances in medical technology and expertise. 71% of deaths worldwide are from non-communicable diseases such as cancer. Cancer is one of the leading causes of death worldwide, with an estimated 23.6 m new cancer cases in 2021 and almost 10m individuals dying from cancer-related causes. (Cancer Collab), rising to 30 million cases and 16m deaths in 2040, a 47% rise from 2020.
The focus of healthcare services is changing - there is increased attention to public health programmes that encourage people not only to stay healthy but also to help them identify when they may have a disease. The use of digital apps and data systems as well as diagnostic infrastructure and equipment to ensure it is easy for people to get diagnosed earlier has increased. Treatment is being revolutionised by genetic testing leading to more personalised treatment as well as the constant introduction of new more targeted pharmaceutical, radiological and surgical interventions. New models of follow-up put the patient in charge and focus on those who most need to be seen. All this is leading to decreased mortality rates and better outcomes for patients.
The UK's leading NHS hospitals want to work with healthcare operators overseas to achieve this success, having over 70 years of experience in innovation using research-based clinical pathways, the most advanced science and excellent training, equipment, and digital systems. A system like this attracts patients and professionals from home and across the world. Equally, ASEAN hosts some of the world's leading hospital providers such as IHH Healthcare, Bangkok Dusit Medical Services, Siloam Hospitals and Raffles Medical Group and many more.
ASEAN and the UK have common challenges and opportunities to learn from each other's experiences, but this is uncoordinated and with a need to understand each other's healthcare landscapes and innovations. A stronger relationship between SE Asia and the UK can help two-way mutual prosperity in health and healthcare.
Key objectives
The desired impact is to generate discussion and deliver insights on the UK's innovation in clinical services and current work examples in the region, all in one showcase. This is a two-way exchange with the ASEAN region, and we will have examples of Southeast Asian organisations presenting their local insights on clinical innovation. Six countries in Southeast Asia, Indonesia, Malaysia, Philippines, Thailand, Singapore, and Vietnam have a deep interest and engagement with the UK on healthcare provision, and the UK is keen to build mutual collaboration with the region on this topic. The result is to generate interest in funded collaboration with the NHS to develop the excellence of clinical services.
This event is part of a wider NHS Innovation series of activities in the region.
British Ambassador to ASEAN
NHS Innovation Specialist at Healthcare UK, Department for Business and Trade
Country Director (Indonesia) of Tony Blair Institute for Global Change
Programme Director, NHS Cancer Programme of Nhs
Commercial Director of Eastern England Academic Health Science Network
VP, International Oncology at AstraZeneca
Innovation Transformation Lead, National Cancer Programme in NHS England
Chief of Cancer Services and Deputy Medical Director at Guyโs and St Thomasโ NHS Foundation Trust
CEO of Angsana Health
Chief Executive at The Christie NHS Foundation Trust
President Director of Mandaya Hospital Group, Indonesia